Anna Konrad

Title: Anna Konrad: Innovator in Site-Specific Labeling of Antibodies

Introduction

Anna Konrad is a notable inventor based in Arsta, Sweden. She has made significant contributions to the field of biochemistry, particularly in the area of antibody labeling. Her innovative approach enhances the functionality of antibodies without compromising their binding capabilities.

Latest Patents

Anna holds a patent for a method of labeling compounds, specifically focusing on site-specific labeling of antibodies or their fragments. The patent describes a process that involves providing an IgG binding protein with a photoactivatable group and at least one label. The method includes mixing the binding protein with the antibodies to be labeled and then using UV illumination for precise labeling. This technique ensures that the antigen binding is not affected, which is crucial for maintaining the efficacy of the antibodies in various applications.

Career Highlights

Anna Konrad is associated with GE Health Bio-Sciences AB, where she applies her expertise in biochemistry to develop innovative solutions. Her work has been instrumental in advancing the field of antibody research and applications. With a patent portfolio that includes one significant patent, Anna continues to push the boundaries of scientific innovation.

Collaborations

Anna collaborates with esteemed colleagues such as Sophia Hober and Amelie Eriksson Karlstrom. These partnerships enhance her research and contribute to the development of cutting-edge technologies in the field.

Conclusion

Anna Konrad is a pioneering inventor whose work in antibody labeling has the potential to impact various scientific and medical fields. Her innovative methods and collaborations reflect her commitment to advancing biochemistry and improving research outcomes.